The Effect of Eucaloric High-Protein Fiber Diet in Healthy Adults: A Repeated Single-Arm Clinical Trial
NCT ID: NCT05455164
Last Updated: 2022-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2020-01-01
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of a High-Protein Liquid Dietary Supplementation
NCT04911712
Modulation of Muscle Protein Synthesis With Diet and Exercise in Old Aged Women
NCT02053441
Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia
NCT04516421
Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.
NCT04054505
Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults
NCT02217579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Without supplementation, followed by Supplementation with Dietary Fibre
For the first two weeks, subjects were given eucaloric prepared meals typical of Indonesian diet, which has low protein and low DF contents (contain less than 15 g/d of DF and protein content less than 15% of total macronutrient distribution range).
After two weeks of washing periods, all of the subjects were given eucaloric prepared meal which contain high protein and DF (contain 25-30 gram DF and protein content between 30-40% of total macronutrient distribution range). At the end of interventions, waist circumference, body weight, body composition, fasting plasma glucose, uric acid, and total cholesterol were measured again. Half of DF content in food came from natural occurring fiber from fruit, vegetables and whole grains, the other half (50%) come from IMO-based fiber supplement (FibercremeⓇ, PT. Lautan Natural Krimerindo, Mojokerto, Indonesia
Isomalto Oligosaccharide
all of the subjects were given eucaloric prepared meal which contain high protein and DF (contain 25-30 gram DF and protein content between 30-40% of total macronutrient distribution range)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isomalto Oligosaccharide
all of the subjects were given eucaloric prepared meal which contain high protein and DF (contain 25-30 gram DF and protein content between 30-40% of total macronutrient distribution range)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy subjects
Exclusion Criteria
* under any medication
* having any kind of diseases and acute infection
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitas Katolik Widya Mandala Surabaya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hendy Wijaya
Head of Clinical Pharmacology research laboratories
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hendy Wijaya, MD.M.Biomed.
Role: PRINCIPAL_INVESTIGATOR
Faculty of Pharmacy, Universitas Katolik Widya Mandala Surabaya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitas Katolik Widya Mandala Surabaya
Surabaya, East Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0295/WM12/KEPK/DSN/T/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.